Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total ...

Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to surviveGroundbreaking PS redu ...

Q3 2025 Earnings Call Transcript November 12, 2025 CorMedix Inc. beats earnings expectations. Reported EPS is $1259.23, ...

Request To Download Free Sample of This Strategic Report @ In 2018, the Clinical Nutrition Market reached a valuation of $313.578 billion, indicating a robust foundation for growth. Over the forecast ...

Early diagnosis of reactive infectious mucocutaneous eruption is important to minimize potential long-term disease ...

From behind a basketball signing table Thursday, 10-year-old Ryker Ammons became the youngest player ever to join the Newman ...

Napo Pharmaceuticals provided a recap of the November 8, 2025 presentation at the North American Society for Pediatric ...

CorMedix CRMD is expected to report its third-quarter 2025 earnings results soon. The Zacks Consensus Estimate for sales and ...

Two year old Ruby suffers from a rare metabolic condition and is one of the stars of Great Ormond Street Hospital Charity’s ...

A 525-gram baby girl, born at 22 weeks and 5 days gestation, was successfully discharged from a Delhi hospital after 105 days ...

Protara is among 50 U.S. employers on BioSpace’s Best Places to Work list, with 20 organizations ranked in large and 30 ranked in small employer categories. Protara received the award in the small ...